विवरण

Combination products include therapeutic or diagnostic products that combine a drug or biologic with a drug delivery device. According to a report by StrategyHelix, the global combination products market is set to increase by US$ 45.60 billion during 2022-2028, growing at a CAGR of 6.8% पूर्वानुमान अवधि के दौरान.

रिपोर्ट अवधि के लिए नवीनतम बाज़ार आकार डेटा प्रदान करती है 2018-2021 और पूर्वानुमान करें 2028 covering key market aspects like sales value for combination products. The global combination products market is segmented on the basis of product, application, and region. On the basis of product, the global combination products market has been segmented into drug/biologic-device combination products, drug-biologic combination products, and drug-device-biologic combination products. By application, the global combination products market has been segmented into cardiovascular, diabetes, cancer treatment, respiratory diseases, और दूसरे. Geographically, the global combination products market is segmented into North America, एशिया प्रशांत, Europe, Middle East and Africa, and Latin America.

The global combination products market is highly competitive. The report also includes the profiles of leading companies such as Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cipla Limited, CosMED Pharmaceutical Co. लिमिटेड, Enable Injections Inc., Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Sanofi S.A., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, The 3M Company, Ypsomed AG.

यह रिपोर्ट इस उद्योग में सक्रिय कंपनियों और संगठनों के लिए एक अमूल्य संसाधन है. It provides a cohesive picture of the combination products market to help drive informed decision making for industry executives, नीति निर्माताओं, अकादमिक, और विश्लेषक.

रिपोर्ट का दायरा

उत्पाद: drug/biologic-device combination products, drug-biologic combination products, and drug-device-biologic combination products
Application: cardiovascular, diabetes, cancer treatment, respiratory diseases, और दूसरे
Region: North America, एशिया प्रशांत, Europe, Middle East and Africa, and Latin America
Years considered: यह रिपोर्ट उस अवधि को कवर करती है 2018 को 2028

हितधारकों के लिए मुख्य लाभ

– Get a comprehensive picture of the global combination products market
– विकास क्षेत्रों और निवेश के रुझानों को इंगित करें

विषयसूची

1. Market definition
2. Research methodology
3. Market data and outlook
3.1 Market size estimates
3.2 Forecast
4. Combination products market by product
4.1 Drug/biologic-device combination products
4.2 Drug-biologic combination products
4.3 Drug-device-biologic combination products
5. Combination products market by application
5.1 Cardiovascular
5.2 Diabetes
5.3 Cancer treatment
5.4 Respiratory diseases
5.5 अन्य
6. Combination products market by region
6.1 North America
6.2 एशिया प्रशांत
6.3 Europe
6.4 Middle East and Africa
6.5 Latin America
7. Company profiles
7.1 Abbott Laboratories
7.2 B. Braun Melsungen AG
7.3 Becton, Dickinson and Company
7.4 Boston Scientific Corporation
7.5 Cipla Limited
7.6 CosMED Pharmaceutical Co., लिमिटेड.
7.7 Enable Injections, इंक.
7.8 Johnson & Johnson
7.9 Medtronic plc
7.10 Novo Nordisk A/S
7.11 Sanofi S.A.
7.12 Smith & Nephew plc
7.13 Stryker Corporation
7.14 Terumo Corporation
7.15 The 3M Company
7.16 Ypsomed AG
8. अनुबंध
8.1 स्ट्रेटेजीहेलिक्स के बारे में
8.2 अस्वीकरण